US$ 29.19
glp-1 agonists vs bariatric surgery weight loss comparison Medication vs. for Loss: Options Matter Bariatric Happy Hour! A cost
Description
There is a risk of weight regain if the medication is discontinued

This amounts to a tremendous global health burden

doi: 10.1056/NEJMoa1603827 11 MarsoSPBainSCConsoliAEliaschewitzFGJdarELeiterLAet al

Jia IT et al

The drug is in a class known as GLP-1 agonists, which were created to treat type 2 diabetes

Whilst evidence is limited, it appears that amylins, a new emerging class of anti-obesity medications, show promise here
